Transcranial ultrasound in Parkinson's disease

The Lancet Neurology

Volumn 7, Issue 5, 2008, Pages 376-378

  Stern, Matthew B ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMELANIN; SYNUCLEIN;

CELL LOSS; CORTICOBASAL DEGENERATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DOPAMINERGIC NERVE CELL; ECHOGRAPHY; HUMAN; LETTER; NEUROIMAGING; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA;

HUMANS; PARKINSON DISEASE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 41949108494     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(08)70068-1     Document Type: Letter

References (6)

1. Gaenslen A., Unmuth B., Godau J., et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 7 (2008) 417-424
2. Berg D., Seifker C., and Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 248 (2001) 684-689
3. Berg D., Merz B., Reiners K., et al. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 20 (2005) 383-385
4. Walter U., Dressler D., Wolters A., et al. Sonographis discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 63 (2004) 504-509
5. Walter U., Dressler D., Wolters A., et al. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia. J Neurol 253 (2006) 448-454
6. Siderowf A., and Stern M. Preclinical diagnosis of Parkinson's Disease. Curr Neurol Neurosci Rep 4 (2006) 295-301